{
  "ptid_time": "007_S_5265_2017-09-18",
  "img_path": "/data/qiuhui/data/adni/images/007_S_5265/2017-09-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 71,864 mm³, 156.0% above the reference mean. With a Z-score of 3.57 (100.0th percentile), this represents profound enlargement; whole brain volume measures 966,405 mm³, 0.8% below the reference mean. With a Z-score of -0.11 (45.8th percentile), this represents normal volume . ",
  "text_data": "Age is 79.1 years. Gender is Female. Education: 18 years. MMSE: 27.0. MoCA: 25.0. Logical Memory: 12.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.77 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.57) with normal whole brain volume, suggesting significant atrophy in regions surrounding the ventricles. Despite high MMSE (27) and MoCA (25) scores, the elevated AV45 (amyloid PET) indicates substantial amyloid deposition, a hallmark of Alzheimer’s pathology. The absence of APOE4 does not rule out AD, as amyloid positivity can occur independently.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to preserved cognitive scores but significant biomarker abnormalities).  \n**Confidence:** **Medium** (cognitive scores are borderline normal, but biomarkers strongly suggest early pathology).  \n\n*Note: If follow-up testing shows cognitive decline, progression to dementia (likely Alzheimer’s) would be expected.*",
  "timestamp": "2025-07-25T22:07:30.942697"
}